A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes

Completed · Phase 3 · Has a placebo group

Conditions studied: Dry Eye

In brief

The objective of this study was to compare the safety and efficacy of 0.25% HL036 Ophthalmic Solutions to placebo for the treatment of the signs and symptoms of dry eye.

Key facts

Study ID
NCT03846453
Run by
HanAll BioPharma Co., Ltd.
People needed
637
Starts
2019-03-10
Expected to finish
2019-11-22
Last updated by the study team
2022-04-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.